SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-23-000079
Filing Date
2023-06-14
Accepted
2023-06-14 16:39:37
Documents
13
Period of Report
2023-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20230609.htm   iXBRL 8-K 45819
2 EX-3.1 evolus0certificateofamendm.htm EX-3.1 8212
  Complete submission text file 0001570562-23-000079.txt   201445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20230609.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20230609_lab.xml EX-101.LAB 25834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20230609_pre.xml EX-101.PRE 13588
7 EXTRACTED XBRL INSTANCE DOCUMENT eols-20230609_htm.xml XML 11566
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 231014645
SIC: 2834 Pharmaceutical Preparations